共 402 条
[11]
Bernardi E(2014)Evolving use of new oral anticoagulants for treatment of venous thromboembolism Blood 124 1020-1028
[12]
Simioni P(2012)Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidencebased clinical practice guidelines Chest 141 24-43
[13]
Girolami B(2012)Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study Thromb Haemost 108 493-498
[14]
Farge D(2008)Epidemiology, risk factors for stroke, and management of atrial fibrillation in China[J] J Am Col Cardiol 52 865-868
[15]
Bounameaux H(2020)Direct oral anticoagulant for the treatment of VTE in cancer patients: a systematic review and meta-analysis Ann Pharmacother 16 1060028020960037-808
[16]
Brenner B(2020)Anticoagulation in deep venous thrombosis: current trends in the era of non-vitamin K antagonists oral anticoagulants. Current Pharmaceutical Design Curr Pharm Des 369 799-772
[17]
Cajfinger F(2013)Oral apixaban for the treatment of acute venous thromboembolism N Engl J Med 11 21-303
[18]
Debourdeau P(2013)Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies Thromb J 129 764-561
[19]
Khorana AA(2014)Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis Circulation 16 1289-667
[20]
Kearon C(2018)NCCN guidelines insights:cancer-associated venous thromboembolic disease, version 2.2018 JNatl Compr Canc Netw 4 550-163